BibTex RIS Cite

İmmun Yetmezlikli Hastalarda İntravenöz İmmünglobulin Tedavisi

Year 2003, Volume: 1 Issue: 1, 92 - 95, 01.09.2003

Sara Şebnem Kılıç

Abstract

Standart intravenöz immunglobulin IVIG preparatları yaklaşık olarak 5000-10000 donör plazmasından elde edilmektedir. Çok sayıda donörden hazırlanması nedeniyle donörlerin doğal enfeksiyon ve immunizasyon ile oluşmuş çok çeşitli tipteki antikorlarını içerirler

References

  • 1. Schwartz SA. Intravenous immunoglobulin treatment of immunodeficiency disorders. Pediatr Clin North Am 2000; 47(6): 1355-1369.
  • 2. Schwartz SA. Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders. J Clin Immunol 1990; 10: 81-89.
  • 3. Douzinas EE, Pitaridis MT. Secondary antibody deficiency states. Crit Care Med 2000; 28: 8-15.
  • 4. Bruton O. A Gammaglobulinemia. Pediatrics 1952; 9: 722- 728.
  • 5. Minegishi R, Rohrer J, Conley ME. Recent progress in the diagnosis and treatment of patients with defects in early B-cell development. Curr Opin Pediatr 1999; 11: 528-532.
  • 6. Cunningam-Rundles C, Bodian C. Common variable immunodeficiency: Clinical and immunological features of 248 patients. Clin Immunol 1999; 92: 34-48.
  • 7. Levy J, Espanol-Boren T, Thomas C, et al. Clinical spectrum of X-linked hyper-Ig M syndrome. J Pediatr 1997; 131: 47-54.
  • 8. Gardulf A, Hammarstrom L, Smith CIE. Home treatment of hypogammaglobulinemia with subcutaneous gammaglobulin by rapid infusion. Lancet 1991; 338:162-166.
  • 9. Misbah SA, Spickett GA, Ryba PC, et al. Chronic enteroviral meningoenephalitis in agammaglobulinemia. J Clin Immunol 1992; 12: 266-270.
  • 10. Duhem C, Dicato MA, Ries F. Side effects of intravenous immuno globulins. Clin Exp Immunol 1994; 97: 79-83.
  • 11. Anonymous. Renal insufficiency and failure associated with immunoglobulin intra venous therapy-United States, 1985-1998. MMWR 1999; 48: 518-521.
  • 12. Tam DA, Morton LD, Stroncek DF, et al. Neutropenia in a patient receiving intravenous immune globulin. J Neuroimmunol 1996; 64:175-178.
  • 13. Brox AG, Cournoyer D, Sternbach M, et al. Hemolytic anemia following intravenous gammaglobulin administration. Am J Med 1987; 82: 633-635.
  • 14. Kessary-Shoham H, Levy Y, Shoenfeld Y, et al. In vivo administration of intravenous immunoglobulin (IVIg) can lead to enhanced erythrocyte sequestration. J Autoimmun 1999; 13:129-135.
  • 15. Koffman BM, Dalakas MC. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases. Muscle Nerve 1997;20:1102-1107.
  • 16. Go RS, Call TG. Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications. Mayo Clin Proc 2000;75:83-85.
  • 17. Bertorini TE, Nance AM, Homer LH, et al. Complications of intravenous gammaglobulin in neuromuscular and other diseases. Muscle Nerve 1996;19:388-391.
  • 18. Lisak RP. Arthritis associated with circulating immune complexes following administration of intravenous immunoglobulin therapy in a patient with chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1996;135:85-88.
  • 19. Siber GR, Werner BG, Halsey NA, et al. Interference of immune globulin with measles and rubella immunization. J Pediatr 1993;122:204-211.

Year 2003, Volume: 1 Issue: 1, 92 - 95, 01.09.2003

Sara Şebnem Kılıç

Abstract

References

  • 1. Schwartz SA. Intravenous immunoglobulin treatment of immunodeficiency disorders. Pediatr Clin North Am 2000; 47(6): 1355-1369.
  • 2. Schwartz SA. Intravenous immunoglobulin (IVIG) for the therapy of autoimmune disorders. J Clin Immunol 1990; 10: 81-89.
  • 3. Douzinas EE, Pitaridis MT. Secondary antibody deficiency states. Crit Care Med 2000; 28: 8-15.
  • 4. Bruton O. A Gammaglobulinemia. Pediatrics 1952; 9: 722- 728.
  • 5. Minegishi R, Rohrer J, Conley ME. Recent progress in the diagnosis and treatment of patients with defects in early B-cell development. Curr Opin Pediatr 1999; 11: 528-532.
  • 6. Cunningam-Rundles C, Bodian C. Common variable immunodeficiency: Clinical and immunological features of 248 patients. Clin Immunol 1999; 92: 34-48.
  • 7. Levy J, Espanol-Boren T, Thomas C, et al. Clinical spectrum of X-linked hyper-Ig M syndrome. J Pediatr 1997; 131: 47-54.
  • 8. Gardulf A, Hammarstrom L, Smith CIE. Home treatment of hypogammaglobulinemia with subcutaneous gammaglobulin by rapid infusion. Lancet 1991; 338:162-166.
  • 9. Misbah SA, Spickett GA, Ryba PC, et al. Chronic enteroviral meningoenephalitis in agammaglobulinemia. J Clin Immunol 1992; 12: 266-270.
  • 10. Duhem C, Dicato MA, Ries F. Side effects of intravenous immuno globulins. Clin Exp Immunol 1994; 97: 79-83.
  • 11. Anonymous. Renal insufficiency and failure associated with immunoglobulin intra venous therapy-United States, 1985-1998. MMWR 1999; 48: 518-521.
  • 12. Tam DA, Morton LD, Stroncek DF, et al. Neutropenia in a patient receiving intravenous immune globulin. J Neuroimmunol 1996; 64:175-178.
  • 13. Brox AG, Cournoyer D, Sternbach M, et al. Hemolytic anemia following intravenous gammaglobulin administration. Am J Med 1987; 82: 633-635.
  • 14. Kessary-Shoham H, Levy Y, Shoenfeld Y, et al. In vivo administration of intravenous immunoglobulin (IVIg) can lead to enhanced erythrocyte sequestration. J Autoimmun 1999; 13:129-135.
  • 15. Koffman BM, Dalakas MC. Effect of high-dose intravenous immunoglobulin on serum chemistry, hematology and lymphocyte subpopulations: assessments based on controlled treatment trials in patients with neurological diseases. Muscle Nerve 1997;20:1102-1107.
  • 16. Go RS, Call TG. Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications. Mayo Clin Proc 2000;75:83-85.
  • 17. Bertorini TE, Nance AM, Homer LH, et al. Complications of intravenous gammaglobulin in neuromuscular and other diseases. Muscle Nerve 1996;19:388-391.
  • 18. Lisak RP. Arthritis associated with circulating immune complexes following administration of intravenous immunoglobulin therapy in a patient with chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 1996;135:85-88.
  • 19. Siber GR, Werner BG, Halsey NA, et al. Interference of immune globulin with measles and rubella immunization. J Pediatr 1993;122:204-211.
There are 19 citations in total.

Details

Primary Language Turkish
Journal Section Collection
Authors

Sara Şebnem Kılıç

Publication Date September 1, 2003
Published in Issue Year 2003 Volume: 1 Issue: 1

Cite

APA Kılıç, S. Ş. (2003). İmmun Yetmezlikli Hastalarda İntravenöz İmmünglobulin Tedavisi. Güncel Pediatri, 1(1), 92-95.
AMA Kılıç SŞ. İmmun Yetmezlikli Hastalarda İntravenöz İmmünglobulin Tedavisi. Güncel Pediatri. September 2003;1(1):92-95.
Chicago Kılıç, Sara Şebnem. “İmmun Yetmezlikli Hastalarda İntravenöz İmmünglobulin Tedavisi”. Güncel Pediatri 1, no. 1 (September 2003): 92-95.
EndNote Kılıç SŞ (September 1, 2003) İmmun Yetmezlikli Hastalarda İntravenöz İmmünglobulin Tedavisi. Güncel Pediatri 1 1 92–95.
IEEE S. Ş. Kılıç, “İmmun Yetmezlikli Hastalarda İntravenöz İmmünglobulin Tedavisi”, Güncel Pediatri, vol. 1, no. 1, pp. 92–95, 2003.
ISNAD Kılıç, Sara Şebnem. “İmmun Yetmezlikli Hastalarda İntravenöz İmmünglobulin Tedavisi”. Güncel Pediatri 1/1 (September 2003), 92-95.
JAMA Kılıç SŞ. İmmun Yetmezlikli Hastalarda İntravenöz İmmünglobulin Tedavisi. Güncel Pediatri. 2003;1:92–95.
MLA Kılıç, Sara Şebnem. “İmmun Yetmezlikli Hastalarda İntravenöz İmmünglobulin Tedavisi”. Güncel Pediatri, vol. 1, no. 1, 2003, pp. 92-95.
Vancouver Kılıç SŞ. İmmun Yetmezlikli Hastalarda İntravenöz İmmünglobulin Tedavisi. Güncel Pediatri. 2003;1(1):92-5.